0649 GMT - Bayer's results should lead to a positive share price response after the company posted better-than-expected earnings and reiterated its outlook, Jefferies analysts say in a note. The German pharmaceutical and agricultural company now forecasts its outlook for the pharma division at the upper end of its guidance range, the analysts say. Its 1Q earnings and sales topped company-compiled and Jefferies' consensus, they say. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
May 13, 2025 02:50 ET (06:50 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.